← Every applicant
Annora Pharma FDA Approvals
56 new drug approvals and 0 device clearances on file. This applicant is not matched to a listed company.
Newest first
A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.
| Product |
|---|
| NORGESTIMATE AND ETHINYL ESTRADIOLNew drugSep 23, 2026TABLET, ORAL-28 |
| LISINOPRILNew drugAug 20, 2026SOLUTION, ORAL |
| DESOGESTREL AND ETHINYL ESTRADIOLNew drugJul 7, 2026TABLET, ORAL-28 |
| DIPHENHYDRAMINE HYDROCHLORIDENew drugJun 17, 2026ELIXIR, ORAL |
| FOSTAMATINIB DISODIUMNew drugJun 17, 2026TABLET, ORAL |
| L-GLUTAMINENew drugMay 26, 2026FOR SOLUTION, ORAL |
| DESOGESTREL AND ETHINYL ESTRADIOLNew drugMar 18, 2026TABLET, ORAL-28 |
| PAROXETINE HYDROCHLORIDENew drugMar 5, 2026SUSPENSION, ORAL |
| MIRTAZAPINENew drugOct 2, 2025TABLET, ORAL |
| BUPROPION HYDROCHLORIDENew drugOct 1, 2025TABLET, EXTENDED RELEASE, ORAL |
| LEVONORGESTRELNew drugSep 30, 2025TABLET, ORAL |
| MESALAMINENew drugAug 13, 2025CAPSULE, EXTENDED RELEASE, ORAL |
| FLUVOXAMINE MALEATENew drugJul 30, 2025CAPSULE, EXTENDED RELEASE, ORAL |
| SPIRONOLACTONENew drugJul 25, 2025TABLET, ORAL |
| ELETRIPTAN HYDROBROMIDENew drugJul 7, 2025TABLET, ORAL |
| INDOMETHACINNew drugJul 3, 2025SUPPOSITORY, RECTAL |
| NITROFURANTOINNew drugJul 2, 2025SUSPENSION, ORAL |
| PRUCALOPRIDE SUCCINATENew drugJun 24, 2025TABLET, ORAL |
| NITAZOXANIDENew drugApr 15, 2025TABLET, ORAL |
| METFORMIN HYDROCHLORIDENew drugMar 13, 2025SOLUTION, ORAL |
| DARUNAVIRNew drugJan 21, 2025TABLET, ORAL |
| SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATENew drugOct 18, 2024SOLUTION, ORAL |
| LURASIDONE HYDROCHLORIDENew drugAug 21, 2024TABLET, ORAL |
| NIMODIPINENew drugJul 9, 2024SOLUTION, ORAL |
| DICYCLOMINE HYDROCHLORIDENew drugJul 1, 2024CAPSULE, ORAL |
| DICYCLOMINE HYDROCHLORIDENew drugMay 7, 2024TABLET, ORAL |
| COLCHICINENew drugApr 29, 2024CAPSULE, ORAL |
| ELTROMBOPAG OLAMINENew drugApr 18, 2024FOR SUSPENSION, ORAL |
| GABAPENTINNew drugFeb 26, 2024TABLET, ORAL |
| MESALAMINENew drugFeb 5, 2024TABLET, DELAYED RELEASE, ORAL |
| GABAPENTINNew drugJan 17, 2024SOLUTION, ORAL |
| DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUMNew drugNov 17, 2023SOLUTION, ORAL, RECTAL |
| PANTOPRAZOLE SODIUMNew drugOct 27, 2023FOR SUSPENSION, DELAYED RELEASE, ORAL |
| DIVALPROEX SODIUMNew drugSep 26, 2023TABLET, EXTENDED RELEASE, ORAL |
| THEOPHYLLINENew drugSep 8, 2023TABLET, EXTENDED RELEASE, ORAL |
| FAMOTIDINENew drugAug 17, 2023FOR SUSPENSION, ORAL |
| EPLERENONENew drugJun 2, 2023TABLET, ORAL |
| BUPROPION HYDROCHLORIDENew drugMay 31, 2023TABLET, EXTENDED RELEASE, ORAL |
| MEXILETINE HYDROCHLORIDENew drugNov 9, 2022CAPSULE, ORAL |
| AMINOCAPROIC ACIDNew drugNov 4, 2022SOLUTION, ORAL |
| PROMETHAZINE HYDROCHLORIDENew drugNov 2, 2022SUPPOSITORY, RECTAL |
| ZILEUTONNew drugOct 11, 2022TABLET, EXTENDED RELEASE, ORAL |
| IVABRADINE HYDROCHLORIDENew drugOct 5, 2022TABLET, ORAL |
| DEFERASIROXNew drugSep 22, 2022GRANULE, ORAL |
| SAPROPTERIN DIHYDROCHLORIDENew drugAug 23, 2022TABLET, ORAL |
| SAPROPTERIN DIHYDROCHLORIDENew drugAug 18, 2022FOR SOLUTION, ORAL |
| GLYCOPYRROLATENew drugJul 5, 2022SOLUTION, ORAL |
| SOLIFENACIN SUCCINATENew drugJun 15, 2022TABLET, ORAL |
| DICLOFENAC POTASSIUMNew drugMar 4, 2022FOR SOLUTION, ORAL |
| ENALAPRIL MALEATENew drugFeb 24, 2022SOLUTION, ORAL |
| OXCARBAZEPINENew drugJan 11, 2022TABLET, ORAL |
| FAMOTIDINENew drugNov 8, 2021TABLET, ORAL |
| FAMOTIDINENew drugNov 4, 2021TABLET, ORAL |
| DEFERASIROXNew drugMay 14, 2021TABLET, ORAL |
| POLYETHYLENE GLYCOL 3350New drugApr 14, 2021FOR SOLUTION, ORAL |
| VIGABATRINNew drugJan 26, 2021FOR SOLUTION, ORAL |